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Soft docking an L and a D peptide to an anticholera toxin
antibody using internal coordinate mechanics
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Background: The tremendous increase in sequential and structural information
is a challenge for computer-assisted modelling to predict the binding modes of
interacting biomolecules. One important area is the structural understanding of
protein–peptide interactions, information that is increasingly important for the
design of biologically active compounds.
Results: We predicted the three-dimensional structure of a complex between
the monoclonal antibody TE33 and its cholera-toxin-derived peptide epitope
VPGSQHID. Using the internal coordinate mechanics (ICM) method of flexible
docking, the bound conformation of the initially extended peptide epitope to
the antibody crystal or modelled structure reproduced the known binding
conformation to a root mean square deviation of between 1.9 Å and 3.1 Å.
The predicted complexes are in good agreement with binding data obtained
from substitutional analyses in which each epitope residue is replaced by all
other amino acids. Furthermore, a de novo prediction of the recently
discovered TE33-binding D peptide dwGsqhydp (single-letter amino acid
code where D amino acids are represented by lower-case letters) explains
results obtained from binding studies with 172 peptide analogues.
Conclusions: Despite the difficulties arising from the huge conformational
space of a peptide, this approach allowed the prediction of the correct
binding orientation and the majority of essential binding features of a
peptide–antibody complex.
Introduction
In contrast to the abundance of docking methods for small
organic ligands (reviewed by Kuntz et al. [1], Verlinde and
Hol [2], and evaluated at the recent Critical Assessment of
Protein Structure Prediction CASP2 [3]), less is known
about the docking of peptides to proteins [4–7]. This is
extremely challenging because peptides have a multidi-
mensional conformational space, which is difficult to
sample exhaustively. However, recent attempts to predict
the binding of relatively short peptides to the SH2 (Src-
homology 2) and PTB (phosphotyrosine-binding)
domains using the internal coordinate mechanics (ICM)
methods with biased stochastic peptide sampling in the
potential field of the receptor gave encouraging results
[8]. In order to evaluate the ability of the ICM docking
procedure [9] to predict binding conformations of pep-
tides that were shown to bind proteins in biochemical
experiments, we investigated the flexible docking of two
peptide epitopes to an antibody. The complex of the
murine monoclonal IgG1 antibody TE33 [10] with the
epitope peptide VPGSQHIDSQKKA derived from
cholera toxin [11] served as a model system, as the three-
dimensional structure of the respective complex [12]
could be used for comparison. To test the ability of the
method to predict previously unknown peptide-binding
conformations, the recently discovered TE33-binding
D peptide epitope dwGsqhydp was docked to the anti-
body. This D peptide analogue has been derived from the
original epitope by successive substitution of L amino
acids with D amino acids [13].
The docking methodology implemented in ICM [9]
includes a computationally efficient optimal-bias Monte-
Carlo minimization method (OBMCM), combined with
pseudo-Brownian random moves [14], an extended force
field including surface terms, electrostatics with the
boundary element solution of the Poisson equation [15],
sidechain entropy terms, and a fast algorithm for calculat-
ing molecular surfaces [16]. In order to save computer
resources, the minimal epitopes were used for docking
experiments. Previous binding studies with a series of
truncated epitope analogues had led to the minimal
sequence VPGSQHID (data not shown). The peptides
were set up in their fully extended conformations. Calcu-
lations were performed using the force field ECEPP/3
[17,18] as implemented in ICM [9], pseudo-Brownian
random movements of position and orientation of the
peptide as well as biased-probability random steps of
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peptide-backbone torsion angles and of selected
peptide-sidechain torsions and random changes of
selected antibody-sidechain torsions. The docking
experiments demonstrated that it is possible to repro-
duce the correct binding orientation and the majority of
essential binding features.
Results
Binding studies using complete substitutional analyses of
TE33-binding peptides
Before starting the docking experiments, binding
studies with a complete set of substitution analogues of
the L peptide VPGSQHID (epitope; Figure 1a) and the
D peptide dwGsqhydp (Figure 1b) [12] revealed
residues critical for binding. The epitope residues
proline 2, glycine 3, serine 4, glutamine 5, and histidine
6 cannot be substituted at all and are thus absolutely
essential for binding. Valine 1 can only be substituted
by another β-branched residue, isoleucine. Aspartate 8
can only be substituted by the other negatively charged
residue, glutamate. Isoleucine 7 can be substituted by
all amino acids and is thus not critical for binding. The
dissociation constant, determined by the method of
Friguet et al. [19] for the peptide–antibody complex is
10–5 mol–1.
Interestingly, although the sequence of the TE33-binding
D analogue is very similar to the epitope with five identi-
cal sidechains (Gsqh and d), the binding pattern in the
substitutional analysis of the D peptide is substantially dif-
ferent from that of the epitope. Here, glycine 3, D histi-
dine 6, and D aspartate 8 lost their property of being key
residues for binding. In this peptide, D serine 4, D gluta-
mine 5, and D tyrosine 7 are most important for binding.
The dissociation constant for this peptide–antibody
complex is 2 × 10–6 mol–1.
Rigid-body and flexible docking of the L peptide epitope to
the X-ray structure derived antibody
In a first set of calculations, the coordinates of the anti-
body were taken from the crystal structure [12].
Rigid-body docking of the minimal epitope VPGSQHID
with coordinates of the respective residues taken from
the crystal structure revealed exact reproduction of
the binding position and orientation of the peptide start-
ing from several different peptide orientations includ-ing
a reverse orientation, after 10,000 energy steps
(not shown).
In the next step, flexible-docking experiments were per-
formed with the fully extended peptide. The binding
site of the peptide was found between 1,500,000 and
2,500,000 energy evaluations, independent of the starting
orientation. The conformation of the peptide after
docking differed slightly for various calculations. The
root mean square deviation (rmsd) of the backbone atoms
of the docked peptide was as low as 1.9 Å. The main dif-
ference is caused by a deviation of the backbone confor-
mation for valine 1 and isoleucine 7. Valine now points to
a hydrophobic pocket formed by residues isoleucine 94 of
the light chain (L94), phenylalanine (L96), and trypto-
phan 50 of the heavy chain (H50) (Figure 2). The ring
planes of proline 2 differ. There is slight deviation of the
backbone atoms for glycine, serine, glutamine and histi-
dine. The serine sidechain makes a hydrogen bond with
serine H96 both in the crystal structure and in the mod-
elled peptide. The sidechain orientations and interac-
tions of glutamine and histidine, both critical for binding,
are reproduced almost perfectly by the docking proce-
dure. The same is true for the aspartate sidechain.
Isoleucine 7, not critical for binding, points towards
residues histidine L31, tyrosine H32 and tryptophan
H100a, whereas in the crystal structure this sidechain
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Figure 1
Substitutional analysis of the peptides (a) VPGSQHID and (b) dwGsqhydp. Each residue of both peptides is either substituted by all L amino
acids (rows, (a)) or D amino acids (rows, (b)) and tested for antibody binding as described [30,31]. Peptides in the left-most columns are
identical wild-type peptides.
points into the solvent. All contacts of the docked pep-
tides with the antibodies are displayed in Figures 3 and
4. The pictures were created using LIGPLOT [20]. All
docking experiments were performed with starting orien-
tations of the peptide centroids about 3 Å apart from the
binding site to spare computer resources.
De novo prediction of the TE33–epitope complex
Three-dimensional coordinates of the free antibody were
created by homology modelling using MODELLER
(Version 3c) [21] based on two homologous murine anti-
bodies. For the light chain the catalytic antibody 28B4
(PDB code 1KEM [22]), which has 93% sequence identity
and identical lengths for all complementarity-determining
regions (CDRs), was chosen. For the heavy chain the anti-
steroid monoclonal antibody DB3 (PDB code 1DBA [23];
80.3% sequence identity) was used. CDR1 and CDR2 are
identical in length. CDR3 of TE33 is three amino-acids
shorter in the N-terminal region, whereas the five C-ter-
minal residues are identical.
In this case, rigid-body docking experiments resulted in
peptide orientations dissimilar (rmsd > 10 Å) to those in the
crystal structure. This was expected because the paratope
of the modelled TE33 Fv (variable) antibody fragment
differs from that of the complexed antibody. Several
sidechains in the CDR regions differ from those in the com-
plexed antibody, whereas the backbone conformations
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Figure 2
Stereoview of the complex of the X-ray derived
antibody TE33 structure with the docked
peptide epitope (red) compared to the peptide
conformation in the crystal structure (yellow).
Peptide hydrogen atoms are omitted. The
N terminus of the peptide is on the right side.
The antibody surface was calculated using the
ICM program. The starting orientation of the
peptide is shown in orange. VH and VL refer,
respectively, to the heavy and light chains of
the antibody variable domain.
Figure 3
Plot of interactions and hydrogen bonds of the complex of the peptide
epitope VPGSQHID with antibody TE33, created with the program
LIGPLOT [20]. (a) The antibody–peptide complex as in the crystal
structure [12]; (b) the complex of docked peptide epitope VPGSQHID
and the antibody from the crystal structure; and (c) the complex of
docked peptide epitope VPGSQHID and the modelled antibody. (P)
indicates residues belonging to the peptide and (H) and (L) refer to
residues in the heavy and light chains of the antibody, respectively.
only differ by an rmsd of 2 Å for the CDR regions. The
overall rmsd is 1.8 Å for all atoms in the Fv fragments,
and 1.0 Å for the backbone atoms. The rmsd values of the
CDR regions are given in Table 1.
Flexible docking of the extended peptide to the mod-
elled antibody now enabled the identification of the
correct binding site and orientation of the ligand. A
starting orientation identical to the one described above
was used. In this case the rmsd of all peptide atoms was
3.8 Å and that of the backbone alone was 3.1 Å
(Figure 5). The C terminus of the docked peptide accu-
rately reproduces that of the peptide in the crystal struc-
ture, whereas the N terminus points towards the
solvent. The interactions of the key residues glutamine
and histidine could again be perfectly predicted,
whereas serine 4 in this case makes an intra-
molecular hydrogen bond with histidine 6 rather than an 
intermolecular hydrogen bond as observed in the crystal
structure (Figure 3). Glutamine 5 makes only one hydro-
gen bond with asparagine H52.
Docking of the D peptide dwGsqhydp to the X-ray structure
derived and modelled antibody TE33
Flexible-docking experiments to the X-ray structure
derived antibody coordinates, starting from the extended
D peptide dwGsqhydp, resulted in a binding conformation
that fits well into a pocket on the antibody surface
(Figure 6). D serine 4, critical for binding, contacts
residues threonine H31, tyrosine H32, glycine H33, and
serine H96 and makes a hydrogen bond with threonine
H31, which is in agreement with the results obtained from
the substitutional analysis. D glutamine contacts residues
serine H96 and tryptophan H100a, making two hydrogen
bonds: one intramolecular bond with glycine 3 and one
intermolecular bond with tryptophan H100a (Figure 4a).
D tyrosine 7 makes a hydrophobic stack with tryptophan
H100a and also forms hydrogen bonds with asparagine
L31d and lysine L50. The C-terminal residues D aspartate
and D proline are not essential for binding and point
towards the solvent.
Docking experiments to the modelled antibody resulted
in a binding conformation with very similar interactions
observed for residues D aspartate 1, D tryptophan 2, and
D tyrosine 7. A clear difference is observed for D glutamine
5, which in this case points to residues threonine H31,
tyrosine H32, and tyrosine H53 (Figure 4b, Figure 6).
D serine 4 contacts residues from CDRs 1 and 2 of the
heavy chain and makes two hydrogen bonds with
asparagine H52 and threonine H52a. D tyrosine 7, which is
critical for binding, points to a hydrophobic pocket formed
by residues tyrosine L54 and the hydrophobic part of argi-
nine H95. It also forms a hydrogen bond with arginine
H95. The C-terminal residues D asparagine and D proline
also point towards the solvent.
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Table 1
Comparison of the modelled antibody TE33 created with
MODELLER [21] with that from the X-ray structure of TE33.
All atoms* Backbone atoms*
VL derived from antibody 28B4 [22]
VL 1.89 1.11
CDR1L 1.20 0.44
CDR2L 1.16 0.19
CDR3L 1.38 0.43
VH derived from antibody DB3 [23]
VH 1.65 0.71
CDRH1 1.21 0.30
CDRH2 1.44 0.27
CDRH3 3.70 0.90
*Rmsd values are in Å.
Figure 4
Plot of interactions and hydrogen bonds of
the complex of the D peptide dwGsqhydp with
antibody TE33, created with LIGPLOT [20].
(a) The complex of D peptide dwGsqhydp and
the antibody from the crystal structure. 
(b) The complex of D peptide dwGsqhydp
and the modelled antibody.
Discussion
Predictions of protein–protein interactions are becoming
increasingly important because of the rapidly growing
numbers of detected novel proteins and their interaction
partners. Stochastic global-optimization algorithms and
the energy function extended with solvation and entropic
effects provides the basis for conformational sampling (for
a review, see [5]). We used the ICM program [9] to predict
the interaction of the epitopes VPGSQHID and
dwGsqhydp with the monoclonal antibody TE33, starting
from the peptide sequence alone — namely, with an
extended peptide conformation.
The first approach using the antibody coordinates from
the complex crystal structure resulted in a prediction that
reproduced the binding site and conformation of the
peptide within the general accuracy range of structure
determination by X-ray crystallography. Interestingly, the
docking procedure produces hydrophobic interactions for
the sidechain of valine 1, whereas in the crystal structure
no such interactions are observed for this sidechain. The
results of the substitutional analysis indicate that there
might be hydrophobic interactions because valine can be
substituted by isoleucine, but with lower binding affinity.
The second approach using a modelled antibody resulted
in an rmsd of the backbone of 3.8 Å for all atoms and 3.1 Å
for the backbone of the peptide. This deviation from the
binding conformation observed in the crystal structure
may well be indicative of the induced-fit mechanism [24]
of the binding process. This could not be simulated
because only dihedral angles of antibody sidechains were
used as free variables, not allowing for any movement of
the flexible CDR loop. It is still extremely computation-
ally demanding to take these variables into account and
that would have made calculations prohibitively expen-
sive. No explicit water molecules were taken into account,
as solvent interactions are implicitly included in the
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Figure 5
Stereoview of the complex of the modelled
antibody TE33 with the docked epitope (red)
compared to the peptide conformation in the
crystal structure (yellow). Peptide hydrogen
atoms are omitted. The N terminus of the
peptide is on the right side. The antibody
surface was calculated using the ICM
program. The starting orientation of the
peptide is shown in orange.
Figure 6
Stereoview of the complex of the antibody
TE33 with the docked D peptide dwGsqhydp
(red: peptide from the complex with the X-ray-
derived antibody; magenta: peptide from the
complex with the modelled antibody). Peptide
hydrogen atoms are omitted. The N terminus
of the peptide is on the right side. The
antibody surface was calculated using the
ICM program. The starting orientation of the
peptide is shown in orange.
extended force field of ICM, including sidechain entropy
effects and protein-surface terms. All docked peptide con-
formations showed negative binding energies
(–6 ± 2 kcal mol-1 for the complex with the antibody coor-
dinates taken from the crystal structure, and
–5 ± 2 kcal mol-1 for the complex with the modelled anti-
body), indicating that a realistic binding scenario was gen-
erated. However, the crystal structure showed the lowest
value (–8 ± 2 kcal mol-1), which indicates that the docked
conformations are not yet ‘perfect’. Elongation of docking
experiments to five million energy evaluations showed no
improvement in energy and binding mode, however. This
means that the docking procedure is ‘trapped’ in low-
energy states, but not necessarily in the global minimum,
possibly as a result of missing movements of the antibody
backbone. Nevertheless, the majority of critical interac-
tions were detected.
No crystal structure is available for the complex of TE33
with the D peptide dwGsqhydp. Therefore, no rigid-body
docking was feasible. The conformations of the D peptide
bound to X-ray-derived TE33 and the modelled antibody
also differed. Calculated binding energies were
–8 ± 2 kcal mol-1 for the complex of dwGsqhydp to the
antibody whose coordinates were taken from the crystal
structure, and –1 ± 2 kcal mol-1 for the complex with the
modelled antibody, respectively. The binding peptide
conformations, although different, fit into the same
binding pocket on the antibody surface and agree well
with the interaction scheme obtained from the substitu-
tional analysis. In particular, the change of key residues’
identity between histidine and isoleucine and D tyrosine is
reflected well by the results of our docking experiments.
The differing results with the D peptide in both experi-
ments may result from alternative conformations of the
binding site, especially the differences in sidechain con-
formations of the antibody. As in the case of the L peptide,
we could not alter the antibody backbone conformation
because of the technical reasons mentioned earlier.
In all experiments the lowest-energy conformation was
considered to be a solution and in the case of the L peptide
epitope this lowest-energy conformation had the lowest
rmsd with respect to the crystal structure, as can be seen in
Figure 7. ICM has already been successful in docking two
proteins with flexible sidechains [25–27], but docking flex-
ible peptides to proteins presents an even more demand-
ing challenge. The results show that the methodology
presented here is suitable for docking peptides to other
proteins, although further improvements of the energy
function as well as larger scale sampling, including sam-
pling of the protein backbone, are necessary. In order to
optimize the reliability of our docking results, we are cur-
rently working on linking biochemical information with
docking techniques.
Biological implications
The interaction of proteins with linear regions of other
protein-binding partners is widely observed in biological-
recognition processes. A variety of protein modules
involved in signal transduction, such as WW (a protein
domain with two highly conserved tryptophan residues),
PDZ (Post synaptic density, Disc large, Zonula occlu-
dens) or SH3 (Src-homology 3) domains interact with
linear peptide epitopes. These binding peptides can be
obtained by screening biologically or chemically generated
libraries or by the yeast-interaction trap system.
Peptide–protein interactions also play a crucial role in the
regulation of the cellular and humoral immune response.
Whereas major histocompatibility (MHC) molecules react
exclusively with linear peptide epitopes, antibodies recog-
nize both linear and nonlinear epitopes. It can, however,
be time consuming or even impossible to analyze these
interactions by X-ray crystallography or NMR. There-
fore, computer-assisted modelling approaches have
become increasingly important. Flexible docking of pep-
tides is especially demanding because of their high confor-
mational flexibility. As a lot of information is available
about the interaction of antibodies with peptides, we chose
the complex of the peptide epitope VPGSQHID with the
anticholera toxin antibody TE33 as a model system for
evaluating our docking strategy.
Materials and methods
Preparation and incubation of complete substitutional analyses have
been described in detail elsewhere [13,28]. All calculations were per-
formed on Silicon Graphics workstations equipped with 64 MB of core
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Figure 7
Plot of ICM energy versus rmsd of the peptide backbone after docking.
Rmsd values of peptide docked to antibody in the TE33 crystal
structure (+) and the rmsd values of peptide docked to modelled TE33
(×) are shown.
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memory. A typical docking run (2500,000 steps) lasted 80–90 central
processing unit (CPU) hours.
In the ICM method, molecules are described by sets of internal coordi-
nates. Relative positions of molecules in complexes and their conforma-
tions form subsets of internal coordinates and can be energy minimized
locally or globally. For our docking experiments of a peptide onto an
antibody the following variables were altered: six positional variables
and 98 internal degrees of freedom (backbone ϕ and φ dihedral angles
and all sidechain dihedrals) of the peptide and sidechain torsion angles
of the binding site of the antibody (all residues that lie within 6 Å of the
peptide in the crystal structure). Other variables were fixed to acceler-
ate conformational sampling and energy calculations. We used
pseudo-Brownian positional movements with an average amplitude of
4 Å for the peptide as well as random rotations around the peptide’s
centre of gravity by an angle close to 15°. Backbone and sidechain
torsion angles of the peptide were sampled one at a time with biased-
probability moves [14] with a maximal amplitude of 180°. Sidechains of
the antibody were randomly changed with a maximal amplitude of 180°.
In a first set of docking experiments we used the coordinates of the
bound antibody TE33 in its complex with the peptide-epitope
sequence VPGSQHIDSQKK from the protein database (PDB code
1TET [12]) and an extended backbone and extended sidechains of the
peptide, with the peptide being placed near to the binding site
(Figure 2). Conversion of the PDB files into objects appropriate for ICM
calculations was accomplished by a regularization procedure. Regular-
ization is required because the experimentally determined PDB struc-
tures often lack hydrogen atoms and positional errors may result in the
unrealistic van der Waals energy even if these structures were energet-
ically refined (because during crystal-structure determinations hydro-
gen atoms are usually not resolved and different force fields are used).
The following steps are required to create the regularized and energy-
refined ICM model of an experimentally determined structure: an
extended all-atom model of a particular protein is generated with
regular geometric characteristics; the nonhydrogen atoms in the model
are assigned to the equivalent atoms in the structure; the regularized
structure is built from the N terminus by adding atoms one by one;
methyl groups are rotated to reduce van der Waals clashes; combined
geometry and energy function are optimized (100-step minimization);
and polar-hydrogen positions are adjusted. This resulted in an rmsd
value of 0.42 Å for the antibody backbone atoms and an rmsd of
0.57 Å for all atoms. Our docking experiments began with an extended
peptide. All experiments required 2,500,000 energy evaluations to con-
verge to the known three-dimensional structure.
In a second set of experiments the antibody TE33 was modelled by
homology modelling using MODELLER [21] and QUANTA (Copy-
right MSI Inc., San Diego, CA, USA). The light chain was modelled
based on a catalytic antibody (PDB code 1KEM [22]), the heavy chain
was based on an anti-progesterone antibody (PDB code 1DBA [23])
keeping in mind that the antibodies optimally have highly homologous
sequences with TE33 and should be unbound. The same docking pro-
cedures as with the native antibody structure were then applied.
With the L peptide epitope we performed calculations with charged
N and C termini of both the antibody and the peptide, as in the crystal
structure. However, this was unlike the biochemical binding experi-
ments where, in practice, the N terminus is uncharged and the C termi-
nus is available as an amide. Uncharged termini were then used in
docking the D peptide epitope dwGsqhydp.
Each of the docking calculations consisted of the following steps:
changing the relative orientation and position of the peptide and — for
flexible docking — the conformation of the backbone or sidechain of the
peptide and the antibody sidechain randomly; optimizing the local
vacuum ECEPP/3 energy [17] with a distance-dependent electrostatic
term by a conjugate-gradient algorithm; calculating surface-based sol-
vation energy and entropic contribution from the sidechains and adding
it to the total potential energy; applying the Metropolis [29] selection
criterion at a temperature of 1500K; and collecting the accepted con-
formations and ranking them according to their potential energies.
The generated conformations, organized in a stack, were compared
and the lowest-energy complex chosen. At the end, binding energies
for all complexes were computed. The binding energies include an
entropy term, a surface term, and an electrostatic term. The calculation
of the surface term included an accurate analytical surface buildup
method [16]. For the electrostatic term of the binding energy the
numerical solution to the Poisson–Boltzmann equation using the
boundary-element algorithm [15,25] was used. The van der Waals term
was neglected because the total contribution of the difference in van
der Waals energies in solvated and bound state can be comparable or
less than the corresponding error. ECEPP/3 [17] atomic partial
charges as implemented in ICM were used for all calculations.
Acknowledgements
This work was supported by grants of the BMBF, Fonds der Chemischen
Industrie and the Charité. Technical assistance of Liying Dong is gratefully
acknowledged. We thank J Anglister and R Arnon for supplying us with the
cell line producing TE33.
References
1. Kuntz, I.D., Shoichet, B.K. & Meng, E.C. (1994). Structure-based
molecular design. Acc. Chem. Res. 27, 117-123.
2. Verlinde, C.L.M.J. & Hol, W.G.J. (1994). Structure-based drug design:
progress, results, and challenges. Structure 2, 577-587.
3. Moult, J., Hubbard, T., Bryant, S.H., Fidelis, K. & Pedersen, J.T. (1997).
Critical assessment of methods of protein structure prediction
(CASP): round II. Proteins supplement 1, 2-6.
4. Frenkel, D., et al., & Westhead, D.R. (1995). PRO_LIGAND: An
approach to de novo molecular design. 4. Application to the design of
peptides. J. Comput. Aided Mol. Des. 9, 213-225.
5. Rosenfeld, R., Vajda, S. & DeLisi, C. (1995). Flexible docking and
design. Annu. Rev. Biophys. Biomol. Struct. 24, 677-700.
6. Desmet, J., Wilson, I.A., Joniau, M., De Maeyer, M. & Lasters, I. (1997).
Computation of the binding of fully flexible peptides to proteins with
flexible side chains. FASEB J. 11, 164-172.
7. Nakajima, N., Higo, J., Kidera, A. & Nakamura, H. (1997). Flexible
docking of a ligand peptide to a receptor protein by multicanonical
molecular dynamics simulation. Chem. Phys. Lett. 278, 297-301.
8. Zhou, Y. & Abagyan, R.A. (1998). How and why phosphotyrosine-
containing peptides bind to the SH2 and PTB domains. Fold. Des.
3, 513-522.
9. Abagyan, R., Totrov, M. & Kuznetsov, D. (1994). ICM – a new method
for protein modelling and design: applications to docking and
structure prediction from the distorted native conformation. J. Comput.
Chem. 15, 488-506.
10. Levy, R., Assulin, O., Scherf, T., Levitt, M. & Anglister, J. (1989).
Probing antibody diversity by 2D NMR: comparison of amino acid
sequences, predicted structures, and observed antibody-antigen
interactions in complexes of two antipeptide antibodies. Biochemistry
28, 7168-7175.
11. Lockman, H. & Kaper, J.B. Nucleotide sequence analysis of the A2
and B subunits of Vibrio cholerae enterotoxin. (1983). J. Biol. Chem.
258, 13722-13726.
12. Shoham, M. Crystal structure of an anticholera toxin peptide complex
at 2.3 Å. (1993). J. Mol. Biol. 232, 1169-1175.
13. Kramer, A., Stigler, R.D., Knaute, T., Hoffmann, B. & Schneider-
Mergener J. (1998). Stepwise transformation of a cholera toxin and a
p24 (HIV-1) epitope into D-peptide analogs. Prot. Eng. 11, 941-948.
14. Abagyan, R. & Totrov, M. (1994). Biased probability Monte Carlo
conformational searches and electrostatic calculations for peptides
and proteins. J. Mol. Biol. 235, 983-1002.
15. Zauhar, R.J. & Morgan, R.S. (1985). A new method for computing the
macromolecular electric potential. J. Mol. Biol. 186, 815-820.
16. Totrov, M. & Abagyan, R. (1996). The contour buildup algorithm to
calculate the analytical molecular surface. J. Struct. Biol. 116, 138-143.
17. Momany, F.A., McGuire, R.F., Burgess, A.W. & Scheraga, H.A. (1975).
Energy parameters in polypeptides. VII. Geometric parameters, partial
atomic charges, nonbonded interactions, hydrogen bond interactions,
and intrinsic torsional potentials for the naturally occurring amino
acids. J. Phys. Chem. 79, 2361-2381.
Research Article  Soft docking a peptide to an antibody Stigler et al.    669
18. Nemethy, G., et al., & Scheraga, H.A. (1992). Energy Parameters in
Polypeptides. 10. Improved geometric parameters and nonbonded
interactions for use in the ECEPP/3 algorithm, with application to
proline-containing peptides. J. Phys. Chem. 96, 6472-6484.
19. Friguet, B., Chaffotte, A.F., Djavadi-Ohaniance, L. & Goldberg, M.E.
(1985). Measurement of the true affinity constant in solution of
antigen-antibody complexes by enzyme-linked immunosorbent assay.
J. Immunol. Methods 77, 305-319.
20. Wallace, A.C., Laskowski, R.A. & Thornton, J.M. (1995). LIGPLOT: A
program to generate schematic diagrams of protein-ligand
interactions. Prot. Eng. 8, 127-134.
21. Sali, A. & Blundell, T.L. (1993). Comparative protein modelling by
satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815.
22. Hsieh-Wilson, L.C., Schultz, P.G. & Stevens, R.C. (1996). Insights into
antibody catalysis: structure of an 2 oxygenation catalyst at 1.9 Å
resolution. Proc. Natl Acad. Sci. USA 93, 5363-5367.
23. Arevalo, J.H., Stura, E.A., Taussig, M.J. & Wilson, I.A. (1993). Three-
dimensional structure of an anti-steroid 2 Fab’ and progesterone-Fab’
complex. J. Mol. Biol. 231, 103-118.
24. Rini, J.M., Schulze-Gahmen, U. & Wilson, I.A. (1992). Structural
evidence for induced fit as a mechanism for antibody-antigen
recognition. Science 255, 959-965.
25. Totrov, M. & Abagyan, R. (1994). Detailed ab-initio prediction of
lysozyme-antibody complex with 1.6 Å accuracy. Nat. Struct. Biol.
1, 259-263.
26. Totrov, M., Abagyan, R. (1997). Flexible protein-ligand docking by
global energy optimization in internal coordinates. Proteins
supplement 1, 215-220.
27. Strynadka, N.C., et al., & James, M.N. (1996). Molecular docking
programs successfully predict the binding of a β-lactamase inhibitory
protein to tem-1 β-lactamase. Nat. Struct. Biol. 3, 233-239.
28. Kramer, A. & Schneider-Mergener, J. (1998). Synthesis and screening
of peptide libraries on continuous cellulose membrane supports.
Methods Mol. Biol. 87, 25-39.
29. Metropolis, N., Rosenbluth, A.W., Rosenbluth, M.N., Teller, A.H. &
Teller, E. (1953). Equation of state calculations by fast computing
machines. J. Chem. Phys. 21, 1087-1092.
30. Kramer, A., Keitel, T., Winkler, K., Stöcklein, W., Höhne, W. &
Schneider-Mergener, J. (1997). Molecular basis for the binding
promiscuity of the anti-p24 (HIV-1) monoclonal antibody. Cell
91, 799-809.
31. Schultz, J., et al., & Oschkinat, H. (1998). Specific interactions
between the syntropin PDZ domain and voltage-gated sodium
channels. Nat. Struct. Biol. 5, 19-24.
670 Structure 1999, Vol 7 No 6
Because Structure with Folding & Design operates a
‘Continuous Publication System’ for Research Papers, this
paper has been published on the internet before being printed
(accessed from http://biomednet.com/cbiology/str). For
further information, see the explanation on the contents page.
